Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes
European Journal of Clinical Investigation · 2025-10 · 55 (10)
DOI: 10.1111/eci.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 16.05.2025. Verfasst von Laura Salmón-Gómez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Fibroblast Growth Factors, Diabetes Mellitus, Type 2, Weight Loss. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Navarra, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) is a comorbidity commonly associated with obesity. Elevated concentrations of growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) are associated with these conditions, making both cytokines interesting candidates to combat them. This study aimed to analyse the relationship between changes in plasma GDF15 and FGF21 levels and the resolution of T2D or obesity improvements after bariatric surgery.
Methods
Plasma samples from 104 patients (52 with obesity and normoglycemia and 52 with obesity and impaired glucose tolerance or T2D) were analysed before and after Roux‐en‐Y‐gastric bypass surgery.
Results
Plasma GDF15 levels increased significantly after bariatric surgery in patients with obesity and normoglycemia ( p < 0.01), as well as in those with obesity and impaired glucose tolerance or T2D ( p < 0.05). This increase was significant in patients analysed up to 8 months after surgery in both groups ( p < 0.01) but not in those analysed between 8 to 15 months after surgery, suggesting that GDF15 concentrations exhibit an early increase after surgery but may return to baseline levels over time. In contrast, plasma FGF21 levels after bariatric surgery decreased significantly in patients with impaired glucose tolerance or T2D ( p < 0.05). Pre‐surgery FGF21 concentrations were negatively correlated with the percentage of excess weight loss and the percentage of fat loss.
Conclusions
GDF15 and FGF21 exhibit a different behaviour after Roux‐en‐Y‐gastric bypass surgery, with FGF21 being more closely associated with glycemic status and weight loss. Elevated pre‐surgery FGF21 concentrations could predict a higher difficulty in losing the excess weight after surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
- Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
- Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
- Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain.
ORCID-Profile: Laura Salmón-Gómez, Victoria Catalán, Beatriz Ramírez, Maite Aguas-Ayesa, Amaia Rodríguez, Sara Becerril, Víctor Valentí, Rafael Moncada, Carolina M Perdomo, Camilo Silva, Javier Escalada, Gema Frühbeck, Javier Gómez-Ambrosi
Förderung
- Gobierno de Navarra
- Instituto de Salud Carlos III
Zitieren
APA
Salmón-Gómez, L., Catalán, V., Ramírez, B., Aguas-Ayesa, M., Rodríguez, A., Becerril, S., Valentí, V., Moncada, R., Perdomo, C. M., Silva, C., Escalada, J., Frühbeck, G., & Gómez-Ambrosi, J. (2025). Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes. European Journal of Clinical Investigation, 55(10). https://doi.org/10.1111/eci.70069
Vancouver
Salmón-Gómez L, Catalán V, Ramírez B, Aguas-Ayesa M, Rodríguez A, Becerril S, et al. Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes. European Journal of Clinical Investigation. 2025;55(10). doi:10.1111/eci.70069
BibTeX
@article{SalmnGmez2025,
author = {Salmón-Gómez, Laura and Catalán, Victoria and Ramírez, Beatriz and Aguas-Ayesa, Maite and Rodríguez, Amaia and Becerril, Sara and Valentí, Víctor and Moncada, Rafael and Perdomo, Carolina M and Silva, Camilo and Escalada, Javier and Frühbeck, Gema and Gómez-Ambrosi, Javier},
title = {Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes},
journal = {European Journal of Clinical Investigation},
year = {2025},
volume = {55},
number = {10},
doi = {10.1111/eci.70069}
}
EUVIMED